Q: Hello 5i team,
Can you please provide an update on NTB since your last comments Sept 12 and include any opinion you have on what effect on share value their revolutionary new drug, CaPre, may have as it enters Phase 3 clinical trials.
as always, thanks for all you do
Gord
Can you please provide an update on NTB since your last comments Sept 12 and include any opinion you have on what effect on share value their revolutionary new drug, CaPre, may have as it enters Phase 3 clinical trials.
as always, thanks for all you do
Gord